Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Zufferey

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Swiss Medical Weekly|December 24, 2013
Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experiencePascal Zufferey, Giorgio Tamborrini, Cem Gabay, et al.
The Journal of Rheumatology|January 17, 2018
Can Ultrasound Be Used to Predict Loss of Remission in Patients with RA in a Real-life Setting? A Multicenter Cohort StudyPascal Zufferey, Almut Scherer, Michael J Nissen, et al.
Annals of the Rheumatic Diseases|June 26, 2020
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohortRaphael Micheroli, Christoph Tellenbach, Almut Scherer, et al.
Arthritis Research & Therapy|July 21, 2017
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritisRaphael Micheroli, Monika Hebeisen, Lukas M Wildi, et al.
Joint Bone Spine|September 27, 2019
Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real lifePascal Zufferey, Delphine S Courvoisier, Michael J Nissen, et al.
The Journal of Rheumatology|November 3, 2014
Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohortAdrian Ciurea, Ulrich Weber, Daniel Stekhoven, et al.
Plos One|March 21, 2020
Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohortMonika Hebeisen, Raphael Micheroli, Almut Scherer, et al.
Rheumatology (Oxford, England)|September 2, 2017
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritisDeshiré Alpizar-Rodriguez, Rüdiger B Mueller, Burkhard Möller, et al.
Scientific Reports|October 18, 2023
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical careMyriam Riek, Almut Scherer, Burkhard Möller, et al.
Rheumatology (Oxford, England)|October 21, 2019
Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three yearsBurkhard Möller, Daniel Aletaha, Michael Andor, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Swiss Medical Weekly|December 24, 2013
Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experiencePascal Zufferey, Giorgio Tamborrini, Cem Gabay, et al.
The Journal of Rheumatology|January 17, 2018
Can Ultrasound Be Used to Predict Loss of Remission in Patients with RA in a Real-life Setting? A Multicenter Cohort StudyPascal Zufferey, Almut Scherer, Michael J Nissen, et al.
Annals of the Rheumatic Diseases|June 26, 2020
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohortRaphael Micheroli, Christoph Tellenbach, Almut Scherer, et al.
Arthritis Research & Therapy|July 21, 2017
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritisRaphael Micheroli, Monika Hebeisen, Lukas M Wildi, et al.
Joint Bone Spine|September 27, 2019
Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real lifePascal Zufferey, Delphine S Courvoisier, Michael J Nissen, et al.
The Journal of Rheumatology|November 3, 2014
Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohortAdrian Ciurea, Ulrich Weber, Daniel Stekhoven, et al.
Plos One|March 21, 2020
Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohortMonika Hebeisen, Raphael Micheroli, Almut Scherer, et al.
Rheumatology (Oxford, England)|September 2, 2017
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritisDeshiré Alpizar-Rodriguez, Rüdiger B Mueller, Burkhard Möller, et al.
Scientific Reports|October 18, 2023
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical careMyriam Riek, Almut Scherer, Burkhard Möller, et al.
Rheumatology (Oxford, England)|October 21, 2019
Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three yearsBurkhard Möller, Daniel Aletaha, Michael Andor, et al.
Pageof 6